Schedule Update - effective 1 August 2002 (text extract)

This is the text extract for Schedule Update - effective 1 August 2002, browse documents here.

PHARMAC

Pharmaceutical Management Agency

New Zealand Pharmaceutical Schedule

UPDATE

Effective 1 August 2002

Cumulative Update for May, June, July & August 2002

Contents

Summary of decisions effective 1 August 2002 ............................................ 3 Colchicine tablets to be fully funded from 1 August 2002 ........................... 4 Continued funding for Green Prescriptions .................................................. 4 Section 29 Medicines .................................................................................... 5 Expiry date for AFT phenoxymethylpenicillin oral liquid now 10 days .......... 5 Methadone injection .................................................................................... 6 Sole Supply expiry ......................................................................................... 7 Tender results ................................................................................................ 8 Possible decisions for implementation 1 September 2002 .......................... 12 Sole Supply products cumulative to August 2002 ...................................... 13 New Listings ............................................................................................... 16 Changes to Restrictions .............................................................................. 18 Changes to Subsidy and Manufacturer’s Price ............................................ 26 Changes to Sole Supply .............................................................................. 31 Corrections ................................................................................................. 34 Delisted Items ............................................................................................. 35 Items to be Delisted .................................................................................... 39 Index ........................................................................................................... 44

Summary of PHARMAC decisions

EFFECTIVE 1 AUGUST 2002

New Listing (page 15)

• Naproxen long-acting tablets 750 mg (Naprosyn SR 750) and 1000 mg (Naprosyn SR 1000) – temporary listing of 28 tablet pack size • Resource Thicken Up 250 g OP – replaces 227 g pack

Increased subsidy (page 26)

• Amoxycillin clavulanate tablets 500/125 mg and oral liquid 125/31.25 mg and 250/62.5 mg per 5 ml (Synermox) • Colchicine tablets 600 µg (Abbott)

Decreased subsidy (page 25–26)

• Bromocriptine mesylate tablets 2.5 mg and 10 mg (Alpha-Bromocriptine) • Clobetasol propionate scalp application 0.05 % (Dermol) • Clonidine tablets 25 µg (Dixarit) • Clonidine tablets 150 µg (Catapres) • Ethynodiol diacetate tablets 500 µg (Femulen) • Glibenclamide tablets 2.5 mg and 5 mg (Gliben) • Ipratropium bromide aqueous nasal spray 0.03 % (Atrovent Nasal Aqueous) • Morphine hydrochloride oral liquid 1 mg per ml, 2 mg per ml, 5 mg per ml and 10 mg per ml (RA- Morph) • Olsalazine capsules 250 mg and tablets 500 mg (Dipentum) • Prednisone tablets 1 mg, 2.5 mg, 5 mg and 20 mg (Apo-Prednisone) • Sulphasalazine tablets 500 mg (Salazopyrin) and EC tablets 500 mg (Salazopyrin EN)

All decisions related to news items are effective from 1 August unless otherwise indicated 3

Colchicine tablets to be fully funded from 1 August 2002

Colchicine is currently the only treatment available on the Pharmaceutical Schedule for patients with acute gout who cannot use non-steroidal anti-inflammatory drugs (NSAIDs). Following a series of price increases over the last few years, colchicine has not been fully subsidised. Following discussions with clinicians, PHARMAC has increased the subsidy to enable colchicine tablets to become fully subsidised from 1 August 2002.

Continued funding for Green Prescriptions

Following the success of the Green Prescription programme over the last three years, PHARMAC has decided to continue funding for the programme. The initiative, jointly funded by PHARMAC and SPARC (Sport and Recreation NZ) aims to encourage people to improve their health by being more active, in consultation with their doctor. Under the programme, Regional Sports Trusts (RSTs) contact patients who have been given Green Prescriptions and establish an activity programme for them. The RSTs usually contact the patient three times over a three-month period with support and follow up. Contact can be ongoing if the patient is given a further green prescription. Surveys conducted over the last three years show more than half of people remain more active six to eight months after receiving their Green Prescription than they were before. More than 70% of patients also report noticing health changes since starting on a Green Prescription. More detailed research on the effects of the programme, both on people’s health and on pharmaceutical usage, is being undertaken in the three-year Heart, Health and Activity study. First results from this study are expected later this year. Until now, the programme has been solely for adults, however following requests from clinicians, SPARC will shortly pilot a Green Prescription programme for children. Further information can be obtained from SPARC’s website: www.sparc.org.nz

All decisions related to news items are effective from 1 August unless otherwise indicated 4

Section 29 Medicines

Section 29 of the Medicines Act 1981 allows for the supply of unregistered medicines to a medical practitioner for use by a named patient under their care. The following details must be notified by the importer or distributor of the unregistered medicine; • Name and dose form of medicine • Month and year of supply • Name and address of supplier. These details must be notified to Medsafe at the end of every month in which the medicine has been supplied. Patient details must be kept by the supplier, including patient and prescriber name, name of medicine, dose form and date. Pharmacists dispensing unregistered medicines are required to supply the New Zealand importer/ distributor with these patient details. Some of the medicines currently available under Section 29 are: • Dapsone tablets 100 mg, available from Pacific Pharmaceuticals. • Propylthiouracil tablets 50 mg, available from Health Support Limited. • Phenylbutazone tablets 100 mg, available from Alpha Pharmaceuticals Unregistered medicines are not funded via the Pharmaceutical Schedule. Funding may be available in some cases through Exceptional Circumstances. The Coordinator Exceptional Circumstances Panel Room 4-28 Building 13, Greenlane Hospital Private Bag 92189, Auckland Tel: 09 630 9943 ext 4343 Fax: 09 631 0753

Expiry date for AFT phenoxymethylpenicillin oral liquid now 10 days

We have been advised by AFT Pharmaceuticals that they have received Medsafe approval to extend the expiry date of reconstituted phenoxymethylpenicillin oral liquid. The reconstituted liquid is now approved as stable for 10 days, when refrigerated and protected from light.

All decisions related to news items are effective from 1 August unless otherwise indicated 5

Methadone injection

Baxter Health Care Ltd has advised PHARMAC that it is temporarily unable to supply its usual brand of methadone injection 10 mg per ml. In order to maintain supply for patients, Baxter has imported the Martindale brand of methadone injection from the United Kingdom. However, this brand is not registered in New Zealand and is not listed on the Pharmaceutical Schedule. PHARMAC is going to utilise the Exceptional Circumstances Scheme to enable the Martindale product to be supplied, fully funded, to patients until the DBL product is again available (expected to be late August). After discussions with the Pharmacy Guild, Baxter, and HealthPAC, the following arrangements have been made: 1. Pharmacists will be supplied the Martindale product directly from Baxter (freephone 0800 229 837). When placing an order, Baxter will require both doctor and patient details to comply with Section 29. Pharmacists will be charged for the product by their usual wholesaler. The Martindale product is in a pack size of 10 (pharmacode 2084783) and the product will be supplied at the same price per ampoule. 2. In order to claim reimbursement for each dispensing of the product, pharmacists will need to obtain an Exceptional Circumstances number. Pharmacists will need to complete an EC application form, and fax it to the EC Coordinator. Pharmacists who have dispensed methadone injection in the last year will receive an EC form by post. If you require a form and have not received one, please contact PHARMAC on 0800 66 00 50. 3. The EC Coordinator will check and approve the application form within 48 hours or sooner, and pass the application to HealthPAC who will assign a unique EC number. 4. HealthPAC will then advise the pharmacist of the EC number. 5. Pharmacists will then forward their claim with the EC number to HealthPAC for reimbursement. We acknowledge that these short term arrangements will inevitably create additional work for all parties, and appreciate the cooperation of pharmacists in the interests of patients.

All decisions related to news items are effective from 1 August unless otherwise indicated 6

Sole Supply expiry

On 30 June each year, the Sole Supply status for a number of products expires. Products for which Sole Supply status expired on 30 June 2002 were identified in the July 2002 Update to the Pharmaceutical Schedule. Please note the following points: • These products will continue to be subsidised on the Pharmaceutical Schedule until such time as PHARMAC notifies otherwise. • Expiry of sole supply status does not mean that other brands (brands not listed on the Pharmaceutical Schedule) will be subisdised from that date. • Only brands listed on the Pharmaceutical Schedule will be subsidised. • Any changes to subsidy or subsidised brands will be provided in the usual way via the Pharmaceutical Schedule Update

All decisions related to news items are effective from 1 August unless otherwise indicated 7

Tender results

Subsidy changes

Chemical Name Presentation; Pack size Current New Date subsidy tender of new subsidy subsidy Sole Supply brand (and supplier) Date of sole supply Brands affected by reference pricing and delisting

Amitriptyline Apomorphine Hydrochloride

50 mg tablets; 100 tablets Inj 10 mg per ml, 1 ml; 5 injections

$6.98 $50.43 $34.80 $28.40 $34.30 $4.02 $4.02 $72.00 $88.01

$4.75 $50.43 $29.95 $24.00 $29.95 $4.02 $4.02 $43.00 $39.60

1 September Amitrip 2002 (Pacific) 1 September Baxter 2002 (Baxter)

1 December 2002 1 December 2002

Atropine Sulphate Inj 400 µg 1 ml; 50 injections Atropine Sulphate Inj 600 µg 1 ml; 50 injections Atropine Sulphate Inj 1200 µg 1 ml; 50 injections Atropine Sulphate Eye drops 0.5%; 15 ml bottle Atropine Sulphate Eye drops 1.0%; 15 ml bottle Cefamandole Nafate Ceftriaxone Sodium Ceftriaxone Sodium Cefuroxime Sodium Cephalexin Monohydrate Cephalexin Monohydrate Cephalexin Monohydrate Cephalexin Monohydrate Cephazolin Sodium Cephazolin Sodium Charcoal Inj 1 g; 10 vials Inj 500 mg; 5 vials Inj 1 g; 5 vials Inj 750 mg; 5 vials 500 mg tablets; 20 tablets

1 September Atropine sulphate 1 December 2002 (AstraZeneca) 2002 1 September Atropine sulphate 1 December 2002 (AstraZeneca) 2002 1 September Atropine sulphate 1 December 2002 (AstraZeneca) 2002 1 September Atropt 2002 Sigma 1 September Atropt 2002 Sigma 1 September Mandol 2002 (Eli Lilly) 1 December 2002 1 December 2002 1 December 2002 Baxter Rocephin Rocephin IM and IV Baxter

1 September Ceftriaxone 1 December 2002 Injection (Novartis) 2002 1 September Ceftriaxone 1 December 2002 Injection (Novartis) 2002 1 September Zinacef (GSK) 2002 1 September Keflex (Eli Lilly) 2002 1 September Keflex (Eli Lilly) 2002 1 September Keflex (Eli Lilly) 2002 1 September Keflex (Eli Lilly) 2002 1 December 2002 1 December 2002 1 December 2002 1 December 2002 1 December 2002

$169.66 $62.50 $30.84 $13.63 $24.00 $10.90 $6.00 $7.00

250 mg capsules; $6.91 20 capsules 125 mg per 5 ml granules for oral liquid 100 ml 250 mg per 5 ml granules for oral liquid 100 ml Inj 500 mg; 1 vial Inj 1 g; 1 vial $8.24

$11.48

$9.50

$3.38 $6.94

$2.03 $4.16 $19.95

1 September Cephazolin 1 December 2002 Injection (Novartis) 2002 1 September Cephazolin 1 December 2002 Injection (Novartis) 2002 1 September Carbosorb 2002 (Pharmacia) 1 December 2002

Baxter Kefzol Baxter Kefzol

50 g per 300 ml $20.00 oral liquids; 300 ml

All decisions related to news items are effective from 1 August unless otherwise indicated 8

Chemical Name

Presentation; Pack size

Current New Date subsidy tender of new subsidy subsidy

Sole Supply brand (and supplier)

Date of sole supply

Brands affected by reference pricing and delisting IsoptoFenicol

Chloramphenicol Chloramphenicol Clotrimazole Co-Trimoxazole

0.5% eye drops; 10 ml bottle Eye oint 1%; 4 g tube Crm 1%; 20 g tube

$1.10 $1.85 $1.00

$1.02 $1.80 $0.80 $7.20

1 September Chlorsig (Sigma) 2002 1 September Chlorsig (Sigma) 2002

1 December 2002 1 December 2002

1 September Clocreme (Pacific) 1 December 2002 2002 1 September Trisul Paediatric 2002 Sugar Free (Pacific) 1 December 2002

AFT Canesten

Oral liq sugar-free $7.95 trimethoprim 40 mg and sulphamethoxazole 200 mg per 5 ml; 500 ml $26.00 $4.81

Cyclophosphamide 50 mg tablets; 50 tablets Dicyclomine Hydrochloride Diphenoxylate Hydrochloride with Atropine Sulphate Erythromycin Ethyl Succinate Erythromycin Ethyl Succinate Erythromycin Ethyl Succinate Folic Acid Heparinised Saline Hypromellose Magnesium Sulphate Medroxyprogesterone Acetate 10 mg tablets; 100 tablets

$25.71 $4.95 $6.00

1 September Cycloblastin 2002 (Pharmacia)

1 December 2002

1 September Merbentyl (Sigma) 1 December 2002 2002 1 September Diastop (Pacific) 2002 1 December 2002 Lomotil

2.5 mg tablets $6.68 with 25 µg atropine sulphate; 100 tablets 200 mg per 5 ml granules for oral liquid; 100 ml 400 mg per 5 ml granules for oral liquid; 100 ml 400 mg tablets 100 tablets 50 µg per ml oral liquid; 25 ml $2.75

$2.75

1 September E-Mycin (Pacific) 1 December 2002 2002 1 September E-Mycin (Pacific) 1 December 2002 2002 1 September E-Mycin (Pacific) 1 December 2002 2002 1 September Folic Acid 2002 (Biomed) 1 December 2002 Pharmacia Baxter Tears Naturale

$4.99

$14.99 $18.50

$14.99 $20.05 $20.00 $2.65

Inj 10 iu per ml, $23.00 5 ml; 50 injections Eye drops 0.3%; 15 ml bottle Inj 49.3%; 50 injections 100 mg tablets; 100 tablets $2.86

1 September Heparinised Saline 1 December 2002 (AstraZeneca) 2002 1 September Poly-Tears (Pacific) 1 December 2002 2002 1 December 2002 1 December 2002 1 December 2002 1 December 2002

$161.40 $161.40 1 September Baxter (Baxter) 2002 $130.33 $104.26 1 September Provera HD 2002 (Pharmacia) $4.75 $41.00 $4.75 $40.93 1 September K Thrombin 2002 (Sigma) 1 September Methoblastin 2002 (Pharmacia)

Menadione 10 mg tablets; Sodium Bisulphite 100 tablets Methotrexate 10 mg tablets; 50 tablets

All decisions related to news items are effective from 1 August unless otherwise indicated 9

Chemical Name

Presentation; Pack size

Current New Date subsidy tender of new subsidy subsidy

Sole Supply brand (and supplier)

Date of sole supply

Brands affected by reference pricing and delisting Baxter Ledertrexate

Methotrexate Metoclopramide Hydrochloride

2.5 mg tablets; 30 tablets 5 mg tablets with 500 mg paracettamol; 60 tablets

$6.15 $7.00

$5.80 $3.25

1 September Methoblastin 2002 (Pharmacia) 1 September Paramax (GSK) 2002

1 December 2002 1 December 2002

Miconazole Nitrate Crm 2%; 20 g tube Midazolam Midazolam Misoprostol Inj 1 mg per ml, 5 ml; 10 Vials Inj 5 mg per ml, 3 ml; 5 Vials 200 µg tablets; 120 tablets

$1.00 $22.60 $24.25 $52.70

$0.90 $15.00 $16.00 $52.70 $20.20 $67.37 $4.15 $30.00 $4.28 $71.71 $4.51

1 September Micreme (Pacific) 1 December 2002 2002 1 September Hypnovel (Roche) 1 December 2002 2002 1 September Hypnovel (Roche) 1 December 2002 2002 1 September Cytotec 2002 (Pharmacia) 1 September Baxter (Baxter) 2002 1 September Baxter (Baxter) 2002 1 September Naphcon Forte 2002 (Pacific) 1 September Norpress 2002 (Pacific) 1 September Mycostatin 2002 (Bristol-Myers) 1 September Baxter (Baxter) 2002 1 September Panadol (GSK) 2002 1 September Panadol (GSK) 2002 1 December 2002 1 December 2002 1 December 2002 1 December 2002 1 December 2002 1 December 2002 1 December 2002 1 December 2002 1 December 2002

AFT Baxter Baxter

Morphine Tartrate Inj 80 mg per ml, $20.20 1.5 ml; 5 injections Morphine Tartrate Inj 80 mg per ml 5 ml; 5 injections Naphazoline Hydrochloride Nortriptyline Hydrochloride Nystatin Oily Phenol Paracetamol Eye drops 0.1%; 15 ml bottle 25 mg tablets; 500 tablets $67.37 $4.20 $46.85

Albalon Allegron Nilstat

Oral liq 100,000 u $4.90 per ml; 24 ml Inj 5%, 5 ml; 5 injections 125 mg Suppositories; 20 Suppositories 250 mg Suppositories; 20 Suppositories Inj 75 mg per ml, 10 ml; 50 injections $71.71 $3.36

Paracetamol

$6.20

$9.38

Potassium Chloride Potassium Chloride

$30.16

$26.00

1 September Potassium Chloride 1 December 2002 (AstraZeneca) 2002 1 September Potassium Chloride 1 December 2002 (AstraZeneca) 2002 1 September Cilicaine (Sigma) 2002 2002 1 September Baxter (Baxter) 2002 2002 1 December 2002 1 December 2002

Pharmacia

Inj 150 mg per ml, $30.50 10 ml; 50 injections $47.60

$26.00 $47.60 $2.50

Pharmacia

Procaine Penicillin Inj 1.5 mega u; 5 injections Sodium Acid Phosphate

16% enema with $2.50 8% sodium phosphate; 1 enema

All decisions related to news items are effective from 1 August unless otherwise indicated 10

Chemical Name

Presentation; Pack size

Current New Date subsidy tender of new subsidy subsidy

Sole Supply brand (and supplier)

Date of sole supply

Brands affected by reference pricing and delisting

Spironolactone Sulphacetamide Sodium Trimethoprim Urea Zinc and Castor Oil

5 mg per ml oral $23.50 liquid; 25 ml bottle Eye drops 10%; 15 ml bottle 300 mg tablets; 50 tablets Crm 10%; 100 g tube Ointment BP; 500 g $4.13 $6.50 $2.96 $6.55

$25.50 $3.60 $6.50 $2.52 $6.20

1 September Spironolactone 2002 (Biomed) 1 September Acetopt (Sigma) 2002 1 September TMP (Pacific) 2002

1 December 2002 1 December 2002 1 December 2002 Aquacare HP Calmurid Douglas IPW Orion PSM Bleph 10

1 September Nutraplus (Pacific) 1 December 2002 2002 2002 1 September Sigma Zinc and 2002 Castor Oil Cream (Sigma) 1 December 2002

Note: Not all tender subsidies have changed. These products have been included as they will have Sole Supply status from 1 December 2002.

Sole Supply changes

Chemical Presentation Pack size New Date of new tender subsidy and subsidy reference pricing $7.55 $5.90 1 June 2002 1 June 2002 Sole supply Date of sole Brands to be brand (and supply and delisted supplier) delisting of affected brands Ipra 250 (Pacific) Ipra 500 (Pacific) 1 September 2002 1 September 2002 Steri-Nebs Steri-Nebs

Ipratropium Bromide Ipratropium Bromide

Nebuliser solution, 500 µg per 2 ml Nebuliser solution, 250 µg per 1 ml or 2 ml

20 20

All decisions related to news items are effective from 1 August unless otherwise indicated 11

Looking forward

This section is designed to alert both pharmacists and prescribers to possible future changes. It may assist pharmacists to manage stock levels and keep prescribers up-to-date with proposals to change the Pharmaceutical Schedule.

Proposals under consideration

The following areas of health care funding are currently under consideration. The PHARMAC Board will be reviewing these proposals, and the decisions taken will be published in future Updates. The dates represented below are the earliest date that these proposals may be implemented. Possible decisions for implementation 1 September 2002 • Methadone oral liquid 2 mg per ml, 5 mg per ml and 10 mg per ml (Biodone, Biodone Forte, Biodone Extra Forte) – subsidy increase • Docusate sodium with sennosides tablets (Coloxyl with senna, Laxsol) – subsidy reduction • Felodipine long-acting tablets 2.5 mg, 5 mg and 10 mg (Plendil) – subsidy reduction • Nifedipine long-acting tablets 10 mg and 60 mg and amlodipine tablets 10 mg – subsidy reduction • Ondansetron tablets and tropisetron capsules – increased access • Lansoprazole capsules (Solox) – new listing • Lansoprazole capsules (Zoton) – removal of Special Authority and subsidy reduction • Pantoprazole tablets (Somac) – subsidy reduction • Mycophenolate mofetil tablets 500 mg (Cellcept) – new listing • Interferon alpha-2a (Roferon-A) – new listing • Levonorgestrel 750 µg tablets (Postinor-2) – subsidy and price increase • Testosterone enanthate 250 mg long-acting injection (Primoteston Depot) – price and subsidy decrease • Buspirone tablets 5 mg and 10 mg (Pacific) – new listing • Fluoxetine 20 mg dispersible tablets (Pacific) – new listing

All decisions related to news items are effective from 1 August unless otherwise indicated 12

Sole Supply products cumulative to August 2002

Sole Supply Products – cumulative to August 2002

Generic Name

Acipimox Acitretin Aciclovir

Presentation

Brand Name Expiry Date*

2004 2004 2003

Cap 250 mg Olbetam Cap 10 mg & 25 mg Neotigason Tab 200 mg Apo-Aciclovir Tab 400 mg & 800 mg Alpha-Aciclovir Tab dispersible 200 mg, 400 mg Acicvir & 800 mg Allopurinol Tab 100 mg & 300 mg Progout Amiloride with Tab 5 mg with Amizide hydrochlorothiazide hydrochlorothiazide 50 mg Amoxycillin Cap 250 mg & 500 mg Ospamox Grans for oral liq 125 mg per 5 ml Ospamox & 250 mg per 5 ml Ospamox Atenolol Tab 50 mg & 100 mg Loten Baclofen Tab 10 mg Pacifen Beclomethasone dipropionate Metered aqueous nasal spray, Alanase 50 µg per dose & 100 µg per dose Aqueous Betahistine dihydrochloride Tab 16 mg Vergo Bisacodyl Suppos 10 mg Fleet Budesonide Metered aqueous nasal spray, Butacort 50 µg per dose & 100 µg per dose Aqueous Captopril Tab 12.5 mg, 25 mg & 50 mg Captohexal Cefaclor monohydrate Cap 250 mg Clorotir Grans for oral liq 125 mg per 5 ml Clorotir Celiprolol Tab 200 mg Celol Clobetasol propionate Crm 0.05% Dermol Oint 0.05% Dermol Clomipramine hydrochloride Tab 25 mg Clopress Clotrimazole Vaginal crm 1% with applicators Clocreme Vaginal crm 2% with applicators Clotrimaderm 2% Pessaries 100 mg with applicator Clotrihexal Pessary 500 mg with applicator Clotrihexal Colestipol hydrochloride Sachets 5 g Colestid Cyclizine lactate Inj 50 mg per ml, 1 ml Valoid Cyproterone acetate Tab 50 mg Siterone Cyproterone acetate Tab 2 mg with ethinyloestradiol Estelle 35 with ethinyloestradiol 35 µg and 7 inert tabs Danthron with poloxamer Oral liq 25 mg with Conthram poloxamer 200 mg per 5 ml Oral liq 75 mg with Conthram Forte poloxamer 1g per 5 ml Desferrioxamine mesylate Inj 500 mg per 10 ml vial Desferal Diazepam Tab 5 mg & 10 mg Pro-Pam Diltiazem hydrochloride Tab 30 mg & 60 mg Dilzem Cap long-acting 120 mg Dilzem SR *Expiry date of the Sole Supply period is 30 June of the year indicated.

2003 2003 2003

2003 2003 2003 2003 2004 2003 2004 2004 2004 2003 2003 2004

2004 2004 2003 2004 2004

2004 2003 2004

Sole Supply Products – cumulative to August 2002

Generic Name

Doxazosin mesylate Doxycycline hydrochloride Enalapril Erythromycin estolate Etidronate disodium Etoposide Flucloxacillin sodium Fluorouracil sodium Fluoxetine hydrochloride Folic acid Frusemide Glyceryl trinitrate Hydrocortisone

Presentation

Tab 2 mg & 4 mg Tab 100 mg Tab 5 mg, 10 mg & 20 mg Tab 500 mg Tab 200 mg Cap 50 mg & 100 mg Cap 250 mg & 500 mg Inj 250 mg, 500 mg & 1 g Inj 500 mg per 10 ml Inj 500 mg per 20 ml Cap 20 mg Tab 5 mg Tab 40 mg Tab 500 mg TDDS 5 mg & TDDS 10 mg Inj 50 mg per ml, 2 ml Inj 125 mg per ml, 2 ml Inj 125 mg per ml, 4 ml Oint 5 mg with cinchocaine hydrochloride 5 mg per g Suppos 5 mg with cinchocaine hydrochloride 5 mg per g Crm 1% with miconazole nitrate 2%

Brand Name Expiry Date*

Dosan Doxine Enahexal Eromycin Etidrate Vepesid Staphlex Flucloxin Baxter Baxter Fluox Apo-Folic Acid Diurin 40 Diurin Nitroderm TTS Solu-Cortef Solu-Cortef Solu-Cortef Proctosedyl Proctosedyl Micreme H 2004 2003 2004 2003 2003 2003 2003 2004 2004 2003 2004 2004 2003 2004 2004 2003 2004 2004 2003 2004 2003 2004 2004 2003 2003 2004 2003

Hydrocortisone with cinchocaine

2004

Lotn 1% with wool fat hydrous 3% DP Lotn HC and mineral oil Cap 500 mg Hydrea Eye drops 0.5% Methopt Eye drops 1% Methopt Forte Indapamide Tab 2.5 mg Naplin Isosorbide mononitrate Tab 20 mg Ismo 20 Tab long-acting 60 mg Duride Lactulose Oral liq 10 g per 15 ml Lactulose Loperamide hydrochloride Cap 2 mg Dicap Loratadine Tab 10 mg Lora-tabs Lorazepam Tab 1 mg & 2.5 mg Lorapam Medroxyprogesterone acetate Inj 150 mg per ml, 1 ml syringe Depo-Provera Megestrol acetate Tab 160 mg Megace Metformin hydrochoride Tab 500 mg & 850 mg Metomin Methotrexate Inj 5 mg per 2 ml vial Baxter Inj 20 mg per 2 ml vial Baxter Inj 50 mg per 2 ml vial Baxter Inj 100 mg per 4 ml vial Baxter *Expiry date of the Sole Supply period is 30 June of the year indicated.

Hydrocortisone with miconazole Hydrocortisone with wool fat and mineral oil Hydroxyurea Hypromellose

Sole Supply Products – cumulative to August 2002

Generic Name

Methyldopa Methylphenidate hydrochloride Miconazole Nadolol Nicotinic acid Nifedipine Ornidazole Phenoxymethylpenicillin (Penicillin V)

Presentation

Tab 125 mg, 250 mg & 500 mg Tab 10 mg Oral gel 20 mg per g Tab 40 mg & 80 mg Tab 25 mg, 50 mg, 100 mg & 500 mg Tab long-acting 20 mg Tab 500 mg Grans for oral liquid benzathine 125 mg per 5 ml Grans for oral liquid benzathine 250 mg per 5 ml Tab 5 mg Tab dispersible 10 mg & 20 mg Tab 1 mg, 2 mg & 5 mg Tab 5 mg Tab 200 mg Tab 300 mg Nebuliser soln, 1 mg per ml, 2.5 ml Nebuliser soln, 2 mg per ml, 2.5 ml Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per 2.5 ml vial, 2.5 ml Tab 5 mg Tab 25 mg & 100 mg Inj 0.9% 5 ml, 10 ml & 20 ml Tab 10 mg & 20 mg Eye drops 0.25% & 0.5% Tab 500 mg Tab 50 mg with hydrochlorothiazide 25 mg Cap 125 mg & 250 mg Inj 50 mg per ml, 10 ml Tab 40 mg & 80 mg Tab long-acting 240 mg Tab (BPC cap strength) Tab, strong, BPC Purified for inj 5 ml, 10 ml & 20 ml

Brand Name Expiry Date*

Prodopa Rubifen Daktarin Apo-Nadolol Apo-Nicotinic Acid Nyefax Retard Tiberal AFT AFT Pindol Piram-D Hyprosin Antinaus Q 200 Q 300 Ventolin Nebules Ventolin Nebules Duolin 2004 2003 2004 2004 2003 2004 2004 2003 2003 2004 2004 2004 2003 2004 2004

Pindolol Piroxicam Prazosin hydrochloride Prochlorperazine Quinine sulphate Salbutamol Salbutamol with ipratropium bromide Selegiline hydrochloride Spironolactone Sodium chloride Tamoxifen citrate Timolol maleate Tranexamic acid Triamterene with hydrochlorothiazide Vancomycin hydrochloride Verapamil hydrochloride Vitamins Vitamin B Complex Water No changes August

Selgene Spirotone Pharmacia Genox Apo-Timop Cyklokapron Triamizide Vancocin Vancocin Verpamil Verpamil SR Healtheries Multivitamin tablets Apo-B-Complex Pharmacia

2003 2003 2004 2003 2004 2004 2003 2004 2003 2004 2003 2004

*Expiry date of the Sole Supply period is 30 June of the year indicated.

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

New Listings

Effective 1 August 2002

110 NAPROXEN

Tab long-acting 750 mg ................................................... 5.77 28 Naprosyn SR 750 Tab long-acting 1,000 mg ................................................ 6.55 28 Naprosyn SR 1000 Note: Temporary listing of 28 pack tablet size. This pack size to be delisted 1 February 2003.

179 RESOURCE THICKEN UP - Special Authority [HP3] ....... 4.00

Note: Replaces 227 g pack size.

250 g OP

Effective 1 July 2002

34 DOCUSATE SODIUM WITH SENNOSIDES

Tab 50 mg with total sennosides 8 mg ............................ 8.09 200 Laxsol

66 BETAMETHASONE DIPROPIONATE

Crm 0.05% in propylene glycol base ............................... 4.33 30 g OP (12.20) Note: Name change only – replaces Diprolene cream Diprosone OV

91 CEFTRIAXONE SODIUM - Hospital pharmacy [HP3]-specialist

a) Subsidised only if prescribed for a dialysis or cystic fibrosis patient; and b) The prescription is endorsed accordingly. Inj 500 mg ..................................................................... 88.01 5 Inj 1 g ........................................................................... 169.66 5 Novartis Novartis

92 CEPHAZOLIN SODIUM - Hospital pharmacy [HP3]

a) Only if prescribed for a dialysis or cystic fibrosis patient; and b) The prescription is endorsed accordingly. Inj 500 mg ....................................................................... 3.38 Inj 1 g ............................................................................... 6.94 Novartis Novartis

1 1

157 CHLORAMPHENICOL

Eye drops 0.5% ................................................................ 1.10 10 ml OP Chlorsig

Effective 1 June 2002

61 GLYCERYL TRINITRATE

Aerosol spray, 400 µg per dose CFC-free ........................ 6.99 200 dose OP Glytrin

71 COAL TAR WITH SALICYCLIC ACID AND SULPHUR

Solution 12% with salicyclic acid 2% and sulphur 4% ointment .............................................. 7.95 40 g OP Cocois 50 g OP Micanol

‡ safety cap reimbursed Sole supplier

72 DITHRANOL

Crm 1% .......................................................................... 27.50

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

New Listings – effective 1 June 2002 (continued)

113 PROBENECID

Tab 500 mg .................................................................... 55.00 100 AFT

Effective 1 May 2002

40 ERYTHROPOIETIN BETA - Special Authority

Inj 6,000 u, pre-filled syringe ....................................... 456.12 6 Recormon Special Authority - Hospital pharmacy [HP3] a) Erythropoietin alpha and beta are indicated in the treatment of anaemia associated with chronic renal failure. b) Erythropoietin alpha and beta are to be given only to patients with the anaemia of end-stage renal failure (other treatable causes of anaemia being excluded) who have been on haemodialysis or continuous ambulatory peritoneal dialysis (CAPD) for at least three months, who are not under evaluation for, or awaiting, a live donor kidney transplant and who meet one or more of the following criteria: 1. Anephric patients 2. Patients who are dependent on regular blood transfusion (1 unit each 4–8 weeks) to maintain haemoglobin > 60 g per litre 3. Patients as in (2) who cannot be transfused because of severe transfusion reactions 4. Transfusion induced haemosiderosis (clinical manifestations, serum ferritin >1,500 ug per ltr) 5. Patients with haemoglobin < 70 g per litre (mean of at least 4 haemoglobin concentrations over 4 months) 6. Patients with haemoglobin < 90 g per litre who have heart failure (low cardiac output, LV ejection fraction <40%) or persistent angina. c) Specialist must make application – renal physicians.

111 LEFLUNOMIDE - Special Authority - Retail pharmacy

Arava Tab 10 mg .................................................................... 176.70 30 Tab 20 mg .................................................................... 242.10 30 Arava Tab 100 mg .................................................................. 121.35 3 Arava Special Authority – Retail Pharmacy a) Patient has rheumatoid arthritis. b) If the patient is a woman of child-bearing age she has adequate contraception and is not pregnant. c) Patient has been unable to tolerate or has a contraindication to or has had an inadequate response to sulphasalazine and methotrexate (individually or in combination). d) Initial application and re-applications to be made by a rheumatologist. Re-application criteria are: 1. compliance (prescriber determined) with medication; and 2. improved rheumatoid arthritis symptom control. e) Prescriptions may be written by any medical practitioner. f) Initial approval is valid for six months. Subsequent approvals are valid indefinitely. Note: patient should have full blood count and liver function tests regularly monitored.

159 BETAXOLOL HYDROCHLORIDE – Retail pharmacy specialist

v Eye v Three

drops 0.5% .............................................................. 15.08

5 ml OP Apo-Betaxolol

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Restrictions

Effective 1 July 2002

46 ATORVASTATIN - Special Authority

Tab 10 mg ...................................................................... 28.40 30 Lipitor Tab 20 mg ...................................................................... 41.39 30 Lipitor Tab 40 mg ...................................................................... 57.40 30 Lipitor Special Authority - Retail pharmacy a) Applications can be made by a general practitioner or relevant specialist. b) Approvals will be granted if the patient fulfills at least one of the criteria outlined in (h) or (i). c) Prescriptions for all patients can be written either by the general practitioner or the relevant specialist. d) All information requested on the application must be supplied. e) Prescribers are required to certify on the Special Authority application that the patient has been offered 3–6 months of counselling and an opportunity to modify lifestyle in the direction which current knowledge suggests would further reduce their risks of cardiovascular morbidity and mortality. f) Attach the results of at least two laboratory tests completed within 12 months of the Special Authority application. At least one of these tests must be fasting (with the exception of patients with IDDM). If a computerised record of cholesterol levels is used, it must be signed by the prescriber. g) Approvals are valid indefinitely. h) General practitioners or relevant specialists may make applications for patients who are in the following risk groups: NHF A1: Patients with proven cardiovascular disease A1:1 – Patients with clinically proven ischaemic total cholesterol > 5.5 heart disease A1:2 – Patients post coronary artery bypass graft total cholesterol > 4.5 (CABG) or angioplasty Patients post heart transplant, regardless of cholesterol level. NHF B: Patients with > 20% 5-year cardiovascular disease risk total cholesterol > 9.0 NHF C: 15-20% 5-year cardiovascular disease risk total cholesterol > 9.0 NHF D: 10-15% 5-year cardiovascular disease risk total cholesterol > 9.0 NHF E: Patients with < 10% 5-year cardiovascular disease risk total cholesterol > 9.0 i) Relevant specialists may make applications for patients in the following risk groups: NHF A1: A1:3 – Patients with proven ischaemic stroke or total cholesterol > 6.0 unequivocal history of transient ischaemic attack due to atherosclerosis A1:4 – Patients with unequivocal history of intermittent total cholesterol > 6.0 claudication NHF A2: Patients with Genetic Lipid Disorders: total cholesterol > 6.0 Familial Hypercholesterolaemia, Familial Defective Apo B, Familial Combined, Dyslipidaemia, Combined Dyslipidaemia (Type III) continued…

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Restrictions – effective 1 July 2002 (continued)

NHF A3: Patients with insulin and non-insulin dependant diabetes, total cholesterol > 6.0 and established nephropathy (albumin excretion greater than 300 mg/day) j) Risk Groups sourced from the 1996 NHF Guidelines for the assessment and management of dyslipidaemia,NZ MED J 1996; 109: 224–32. Note: Patients with a total cholesterol level greater than 9 mmol/l should have their initial assessment undertaken by a specialist.

72 & 141 CYCLOSPORIN A - Special Authority - Hospital pharmacy [HP3]

Oral liq 100 mg per ml ................................................. 377.38 50 ml OP Neoral

Changes to Restrictions – effective 1 June 2002

63 FRAMYCETIN SULPHATE WITH GRAMICIDIN

a) Only on a prescription, b) Not in combination. Oint 1.5% with gramicidin 0.005% ................................... 6.60 15 g OP (9.20)

Soframycin

63 FUSIDIC ACID

a) Only on a prescription, b) Not in combination, c) Maximum 15 g per prescription. Crm 2% ............................................................................ 6.60 Oint 2% ............................................................................ 6.60 Gel 2% ............................................................................. 6.60

15 g OP Fucidin 15 g OP Fucidin 15 g OP Fucidin

63 MUPIROCIN

a) Only on a prescription, b) Not in combination. Oint 2% ............................................................................ 6.60 15 g OP (8.24)

Bactroban

63 POLYNOXYLIN

a) Only on a prescription, b) Not in combination. Gel 3.50 ......................................................................... 15 g OP (5.87)

Ponoxylan

v Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Restrictions – effective 1 June 2002 (continued)

63 SILVER SULPHADIAZINE

a) Only on a PSO, b) Not in combination. Crm 1% with chlorhexidine digluconate 0.2% .................. 8.45 50 g OP (11.30) Crm 1% with chlorhexidine digluconate 0.2% ................ 10.80 100 g OP (14.64) Crm 1% with chlorhexidine digluconate 0.2% ................ 32.40 500 g OP (45.88)

Silvazine Silvazine Silvazine

63 AMOROLFINE – Not in combination

Nail soln 5% ................................................................... 37.86 5 ml OP (60.07) Loceryl

63 CICLOPIROXOLAMINE – Not in combination

Crm 1% ............................................................................ 1.00 20 g OP (9.63) Batrafen Soln 1% ............................................................................ 4.36 20 ml OP (9.08) Batrafen Nail soln 8% ................................................................... 37.81 3.5 ml OP Batrafen

64 CLOTRIMAZOLE – Not in combination

Crm 1% ............................................................................ 1.00 15 g OP (1.83) AFT Crm 1% ............................................................................ 1.00 20 g OP Clocreme IMM (4.60) CanestenIMM Soln 1% ............................................................................ 4.36 20 ml OP (7.35) CanestenIMM

64 ECONAZOLE NITRATE – Not in combination

Crm 1% ............................................................................ 1.00 (5.77) Crm 1% ............................................................................ 1.00 (9.60) Foaming soln 1%, 10 ml sachets ..................................... 9.89 (11.30) Soln 1% ............................................................................ 4.36 (6.70) Soln 1% ............................................................................ 4.36 (10.22) 15 g OP Ecreme Pevaryl 30 g OP Pevaryl 3 Pevaryl 10 ml OP Pevaryl 30 ml OP Pevaryl

64 KETOCONAZOLE – Not in combination

Crm 2% ............................................................................ 1.00 15 g OP (10.00)

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

Nizoral

‡ safety cap reimbursed Sole supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Restrictions – effective 1 June 2002 (continued)

64 MICONAZOLE NITRATE – Not in combination

Crm 2% ............................................................................ 1.00 (1.83) Crm 2% ............................................................................ 1.00 Lotn 2% ............................................................................ 4.36 (9.88) Tincture 2% ...................................................................... 4.36 (11.33) 15 g OP AFT Micreme 20 g OP 30 ml OP Daktarin 30 ml OP Daktarin

64 NYSTATIN – Not in combination

Crm 100,000 u per g ....................................................... 1.00 15 g OP (4.10) (4.64) Oint 100,000 u per g ........................................................ 1.00 15 g OP (4.10) (4.91) Paste 100,000 u per g, 30 g ............................................ 1.00 30 g OP (7.30) Nilstat Mycostatin Nilstat Mycostatin Mycostatin

64 TIOCONAZOLE – Not in combination

Crm 1% ............................................................................ 1.00 30 g OP (8.60) Lotn 1% ............................................................................ 4.36 30 ml OP (8.70) Trosyd Trosyd

65 TOLCICLATE – Not in combination

Crm 1% ............................................................................ 1.00 30 g OP (5.76) Tolmicen

65 TOLNAFTATE – Not in combination

Crm 1% ............................................................................ 1.00 20 g OP (8.35) Soln 1% ............................................................................ 4.36 10 ml OP (6.67) Tinaderm Tinaderm

65 CALAMINE – Not in combination

Crm, aqueous, BP .......................................................... 17.10 500 g (21.75) Lotn, BP ......................................................................... 21.60 2,000 ml (24.50) PSM PSM

v Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Restrictions – effective 1 June 2002 (continued)

65 CROTAMITON – Not in combination

Crm 10% .......................................................................... 4.26 20 g OP (4.45) Lotn 10% .......................................................................... 7.56 50 ml (7.70) Eurax Eurax

68 BETAMETHASONE DIPROPIONATE WITH CLOTRIMAZOLE – Only on a prescription

Crm 0.05% with clotrimazole 1% ..................................... 4.90 15 g OP (7.95) Lotricomb

68 BETAMETHASONE DIPROPIONATE WITH SALICYLIC ACID – Only on a prescription

Oint 0.05% with salicylic acid 3% .................................... 8.10 30 g OP (10.95) Lotn 0.05% with salicylic acid 2% .................................... 9.74 50 ml OP (13.80) Diprosalic Diprosalic

116 PARACETAMOL

‡ Oral liq 120 mg per 5 ml .................................................. 8.10 a) Available on a PSO b)Not in combination (9.15) 1,000 ml Paracare Junior Suspension PSM Paracetamol Elixir Paediatric Douglas Pamol 1,000 ml Paracare Double Strength Suspension Douglas Pamol

(14.80) ‡ Oral liq 250 mg per 5 ml – Not in combination ............... 8.10

(9.15) (19.00)

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Restrictions – effective 1 June 2002 (continued)

128 QUETIAPINE - Special Authority Subsidy by endorsement

Tab 25 mg ...................................................................... 55.00 60 Seroquel Tab 100 mg .................................................................. 110.00 60 Seroquel Tab 150 mg .................................................................. 159.00 60 Seroquel Tab 200 mg .................................................................. 210.00 60 Seroquel Special Authority - Retail pharmacy a) Not subject to limited patient numbers. b) Subsidised for: i) patients presenting with first episode schizophrenia or related psychoses; and ii)patients suffering from schizophrenia and related psychoses who are likely to benefit from anti-psychotic treatment after trial of an effective dose of risperidone that has been discontinued because of unacceptable side effects or inadequate response. c) Initial application and application for renewal of Special Authority to be made by a psychiatrist. d) First prescription to be written by a psychiatrist or psychiatric registrar. e) Subsequent prescriptions may be written by a General Practitioner. f) Approvals valid for two years Retail pharmacy – subsidy by endorsement a) Subsidised for: i) patients presenting with first episode schizophrenia or related psychoses; and ii) patients suffering from schizophrenia or related psychoses after a trial of an effective dose of risperidone that has been discontinued because of unacceptable side effects or inadequate response. b) Initial prescription must be written by a relevant specialist. c) Subsequent prescriptions may be written by a general practitioner. d) The prescription must be endorsed “certified condition”.

Inhaled beta-adrenoceptor agonists - long acting Metered dose inhalers

149 SALMETEROL - Special Authority

Aerosol inhaler, 25 µg per dose ..................................... 33.75 120 dose OP Serevent

Breath activated devices

149 EFORMOTEROL FUMARATE

Powder for inhalation, 6 µg per dose, breath activated - Subsidy by endorsement .......................................................... 21.50 60 dose OP Oxis Turbuhaler Subsidy is available for patients with poorly controlled asthma where: a) at least three months of 750 µg or more daily of inhaled beclomethasone or budesonide (or 400 µg of fluticasone) for adults has been used; or b) at least three months of 400 µg or more daily of inhaled beclomethasone or budesonide (or 200 µg of fluticasone) for children 12 years or older has been used; The prescription must be endorsed accordingly. We recommend that the words used to indicate eligibility are “poor control with ICS” or “certified condition”.

v Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Restrictions – effective 1 June 2002 (continued)

150 BUDESONIDE WITH EFORMOTEROL - Special Authority

Powder for inhalation 100 µg with eformoterol fumarate 6 µg ............................................................. 74.10 120 dose OP Symbicort Turbuhaler 100/6 Powder for inhalation 200 µg with eformoterol fumarate 6 µg ............................................................. 90.80 120 dose OP Symbicort Turbuhaler 200/6

150 EFORMOTEROL FUMARATE - Special Authority

Powder for inhalation, 12 µg per dose, and monodose device ....................................................... 35.80 60 doses Foradil Powder for inhalation, 12 µg per dose, breath activated .......................................................... 35.80 60 dose OP Oxis Turbuhaler

150 SALMETEROL - Special Authority

Powder for inhalation, 50 µg per dose, 4 doses per disk ......................................................... 35.80 15 disks Serevent Powder for inhalation, 50 µg per dose, breath activated .......................................................... 35.80 60 dose OP Serevent Accuhaler Special Authority - Retail pharmacy for eformoterol fumarate (12 µg per dose), eformoterol fumarate with budesonide and salmeterol . a) Special Authority criteria either under point I (in its entirety), or point II (in its entirety), or point III (in its entirety) must apply before patients have access to subsidy. b) Special Authority approvals (CHEM numbers) are interchangeable among all presentations of inhaled long-acting beta agonists and eformoterol fumarate with budesonide. c) Applications for Special Authority to be made by general practitioners or an appropriate specialist. d) Approvals valid for two years. e) Patients are to be reviewed at least at six months to assess compliance and effectiveness of therapy. f) Applications to be made on a PHARMAC approved form. g) The re-application criteria under each point below (I, II or III) are: 1) compliance (prescriber determined) with medication; and (2) improved asthma symptom control. h) Children who turn 12, and are stabilised on an inhaled LABA, are not required to try Oxis Turbuhaler 6 µg in order to have continued access to their original inhaled LABA. I. Serevent MDI, Serevent Diskhaler, Serevent Accuhaler, Foradil, Oxis Turbuhaler 12 µg1, Symbicort Turbuhaler Subsidy is available for: - children with poorly controlled asthma under the age of 12 who required at least three months of 400 µg or more daily inhaled beclomethasone or budesonide (or 200 µg or more of fluticasone); or - adults with poorly controlled asthma who required at least three months of 1,500 µg or more daily of inhaled beclomethasone or budesonide (or 750 µg or more of fluticasone). continued…

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy ‡ safety cap reimbursed Sole supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Restrictions – effective 1 June 2002 (continued)

Note that as of 1 October 2001 only Serevent MDI, Serevent Diskhaler, Serevent Accuhaler, Foradil and Symbicort Turbuhaler 100/6 and 200/6 are approved by Medsafe for the use in paediatric patients under the age of 12 years. Please refer to the relevant data sheets for details. II. Serevent MDI, Serevent Diskhaler, Serevent Accuhaler Subsidy is available for patients with poorly controlled asthma aged 12 years and over, under the following criteria: - at least three months of 750 µg or more daily of inhaled beclomethasone or budesonide (or 400 µg of fluticasone) for adults, or 400 µg or more daily inhaled beclomethasone or budesonide (or 200 µg of fluticasone) for children 12 years or older has been used; and - patients either: • are hypersensitive to eformoterol; or • have developed a product related adverse event that resolved on cessation and recurred on re-challenge with Oxis Turbuhaler 6 µg; or • after a six week trial of Oxis Turbuhaler 6 µg (with doses of 12–24 µg daily) failed to show evidence of improved asthma control. III. Serevent MDI and spacer (with or without mask) Subsidy is available in rare circumstances for patients with poorly controlled asthma aged 12 years and over, under the following criteria: - have documented serious mental or physical2 disability who are incapable of being taught to use the appropriate breath activated device; and - at least three months of 750 µg or more daily of inhaled beclomethasone or budesonide (or 400 µg of fluticasone) for adults, or 400 µg or more daily inhaled beclomethasone or budesonide (or 200 µg of fluticasone) for children 12 years or older has been used; ii) Applications must be made on a PHARMAC approved form, which contains a free text box for “Turbuhaler failures” where the nature of the documented serious mental or physical disability is to be recorded. 2 Hand grips for the Turbuhaler are available free of charge from AstraZeneca for patients with problems with manual dexterity.

Effective 1 May 2002

38 CALCITRIOL - Retail pharmacy-specialist

Oral liq 1 µg per ml - Special Authority .......................... 39.40 10 ml OP Rocaltrol solution Special Authority - Hospital pharmacy [HP3] a) Oral liquid for patients with oesophageal stricture who are unable to take capsules. General Practitioner or appropriate specialist may make application. b) Oral liquid for infants and children with liver disease or short gut syndrome, who require vitamin supplementation but are unable to swallow capsules. Paediatricians may make application.

53 CAPTOPRIL

‡ Oral liq 5 mg per ml .......................................................... 44.38 95 ml OP Capoten ‡ Oral liq 5 mg per ml .......................................................... 44.38 100 ml OP Capoten a) Oral liquid restricted to children under seven 12 years of age.

v Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 August 2002

24 OLSALAZINE - Retail pharmacy-specialist (↓subsidy)

Cap 250 mg ................................................................... 31.51 Tab 500 mg .................................................................... 59.86 100 100 Dipentum Dipentum Salazopyrin Salazopyrin EN Gliben Gliben Catapres

24 SULPHASALAZINE (↓subsidy)

Tab 500 mg ...................................................................... 8.86 Tab EC 500 mg ................................................................ 9.94 100 100

31 GLIBENCLAMIDE (↓subsidy)

Tab 2.5 mg ....................................................................... 1.98 Tab 5 mg .......................................................................... 2.10 100 100

59 CLONIDINE (↓subsidy)

Tab 150 µg ..................................................................... 29.33 100

73 CLOBETASOL PROPIONATE (↓subsidy)

Scalp app 0.05% .............................................................. 2.50 30 ml OP Dermol

77 ETHINYLOESTRADIOL WITH GESTODENE - Available on a PSO (↑price)

Tab 30 µg with gestodene 75 µg ..................................... 3.15 (5.00) Tab 30 µg with gestodene 75 µg and 7 inert tab ............. 3.15 (5.00) 21 Femodene 21 28 Femodene 28

78 ETHINYLOESTRADIOL WITH LEVONORGESTREL - Available on a PSO (↑price)

Tab 30 µg with levonorgestrel 150 µg ............................. 3.15 (5.00) Tab 30 µg with levonorgestrel 150 µg and 7 inert tab ..... 3.15 (5.00) 21 Microgynon 30 28 Microgynon 30 ED

79 ETHYNODIOL DIACETATE - Available on a PSO (↓subsidy)

Tab 500 µg ....................................................................... 6.62 84 Femulen Apo-Prednisone Apo-Prednisone Apo-Prednisone Apo-Prednisone

84 PREDNISONE (↓subsidy)

Tab 1 mg .......................................................................... 9.99 Tab 2.5 mg ..................................................................... 11.41 v Tab 5 mg - Available on a PSO ....................................... 11.98 v Tab 20 mg ...................................................................... 35.41

v v

500 500 500 500

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Subsidy and Manufacturer’s Price – effective 1 August 2002 (continued)

90 & 126 BROMOCRIPTINE MESYLATE (↓subsidy)

Tab 2.5 mg ..................................................................... 33.24 Tab 10 mg .................................................................... 123.96 100 100 AlphaBromocriptine AlphaBromocriptine

95 AMOXYCILLIN CLAVULANATE - Available on a PSO (↑price,↑subsidy)

Tab amoxycillin 500 mg with potassium clavulanate 125 mg ................................... 37.42 Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml .............. 3.43 Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml .............. 5.89 100 100 ml 100 ml Synermox Synermox Synermox Apo-Ethambutol Abbott RA-Morph RA-Morph RA-Morph RA-Morph

99 ETHAMBUTOL - Retail pharmacy-specialist (↓price)

Tab 400 mg .................................................................... 40.80 100

113 COLCHICINE (↑subsidy)

Tab 600 µg ..................................................................... 16.50 100

117 MORPHINE HYDROCHLORIDE - Only on a controlled drug form (↓subsidy)

‡ ‡ ‡ ‡ Oral liq 1 mg per ml ......................................................... 7.68 Oral liq 2 mg per ml ......................................................... 8.15 Oral liq 5 mg per ml ......................................................... 9.18 Oral liq 10 mg per ml ..................................................... 11.96 200 ml 200 ml 200 ml 200 ml

119 NORTRIPTYLINE HYDROCHLORIDE (↑price)

Tab 10 mg ........................................................................ 2.40 (4.80) Tab 25 mg ........................................................................ 9.37 (18.80) 50 Allegron 100 Allegron

124 CLONIDINE HYDROCHLORIDE (↓subsidy)

Tab 25 µg ....................................................................... 15.53 100 Dixarit

155 IPRATROPIUM BROMIDE (↓subsidy)

Aqueous nasal spray, 0.03% .......................................... 11.79 15 ml OP Atrovent Nasal Aqueous

v Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Effective 1 July 2002

41 TRANEXAMIC ACID (↓subsidy)

Tab 500 mg .................................................................... 50.40 100 Cyklokapron

74 SUNSCREENS, PROPRIETARY - Retail pharmacy-specialist (↑price)

Lotn .................................................................................. 4.80 125 ml OP (9.45) Aquasun 30+ Aquabloc 30+

82 ALENDRONATE - Special Authority (↓subsidy,↓price)

Tab 10 mg ...................................................................... 51.30 Tab 70 mg ...................................................................... 47.90 30 4 Fosamax Fosamax Nifuran Nifuran

108 NITROFURANTOIN (↑subsidy,↑price)

Tab 50 mg ...................................................................... 14.70 Tab 100 mg .................................................................... 25.70 100 100

121 & 127 LITHIUM CARBONATE (↑subsidy,↑price)

Tab long-acting 400 mg ................................................. 13.35 100 Priadel

159 BETAXOLOL HYDROCHLORIDE - Retail pharmacy-specialist

Eye drops 0.5% (↓subsidy) ............................................ 7.54 (15.08)

5 ml OP Apo-Betaxolol Betoptic

Effective 1 June 2002

23 SIMETHICONE (price correction)

Tab aluminium hydroxide 200 mg with magnesium hydroxide 200 mg and activated simethicone 20 mg .................... 4.50 (12.45) 300 Mylanta

25 ZINC OXIDE (price correction)

Oint zinc oxide with balsam peru ..................................... 4.50 50 g OP (6.25) Suppos zinc oxide with balsam peru ................................ 4.47 12 (6.10) Anusol Anusol

61 GLYCERYL TRINITRATE (↓subsidy)

Oral pump spray 400 µg per dose ................................... 6.99 200 dose OP (9.05) Nitrolingual Pumpspray

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Subsidy and Manufacturer’s Price – effective 1 June 2002 (continued)

74 SUNSCREENS, PROPRIETARY - Retail pharmacy-specialist

Crm (Price correction) ..................................................... 1.74 50 g OP (6.00) Oint (↑price) ................................................................... 5.00 14 g OP (15.00) Lotn (Price correction) ..................................................... 4.80 125 ml OP (8.85) Aquasun 30+ R V Paque

Aquasun 30+ Aquabloc 30+

116 PARACETAMOL (Price correction)

‡ Oral liq 120 mg per 5 ml - Available on a PSO ................. 8.10 1,000 ml (14.80) ‡ Oral liq 250 mg per 5 ml .................................................. 8.10 1,000 ml (19.00) Pamol Pamol Xenazine 25 Ipra 250 Steri-Nebs Ipra 500 Steri-Nebs

132 TETRABENAZINE (↑subsidy & ↑price)

Tab 25 mg .................................................................... 243.00 112

152 IPRATROPIUM BROMIDE - Available on a PSO (↓subsidy)

Nebuliser soln, 250 µg per 1 ml, 1 ml ............................. 5.90 (7.80) Nebuliser soln, 500 µg per 2 ml, 2 ml ............................. 7.55 (11.20) Special Foods 20 20

183 INFASOY (↑price) .............................................................. 6.34

(14.55)

900 g OP

Effective 1 May 2002

23 SIMETHICONE (price correction)

Oral liq aluminium hydroxide 200 mg with magnesium hydroxide 200 mg and activated simethicone 20 mg per 5 ml ...... 1.50 500 ml (4.05)

Mylanta P

69 ZINC AND CASTOR OIL (↑price)

Ointment BP ..................................................................... 6.55 (45.00) 500 g Orion

v Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Subsidy and Manufacturer’s Price – effective 1 May 2002 (continued)

70 & 170 PARAFFIN (↓subsidy)

White soft ....................................................................... 17.89 2,500 g IPW (39.50) PSM a) Only in combination with a dermatological galenical or as a diluent for a proprietary Topical Corticosteroid - Plain.

70 POVIDONE IODINE (↑price)

Antiseptic soln 10% ......................................................... 6.42 (7.20) Alcohol skin preparation 10% ........................................... 8.13 (14.20) 500 ml ViodineIMM 500 ml Viodine

73 & 171 SALICYLIC ACID (↓subsidy)

Powder .................................................................... 29.52 500 g David Craig (38.40) PSM a) Only in combination with a dermatological base or proprietary Topical Corticosteroid - Plain; b) With or without other dermatological galenicals.

79 LEVONORGESTREL - Available on a PSO (↑price)

Tab 30 µg ......................................................................... 2.90 (4.83) 28 Microlut

169 ACETYLCYSTEINE (↑price)

Inj 200 mg per ml, 10 ml ............................................. 137.06 (242.50) 10 Parvolex

169 GLYCEROL (↓subsidy) ................................................ 26.66

2,000 ml David Craig (29.00) PSM (Only in extemporaneously compounded methadone mixture, codeine linctus diabetic or codeine linctus paediatric)

179 HORLEYS BREAD MIX (↑price) ........................................ 3.51 1,000 g OP (5.49) 179 HORLEYS FLOUR (↑price) ................................................ 5.62 2,000 g OP (9.46)

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Sole Supply

Effective 1 July 2002

145 LORATADINE

Tab 10 mg ........................................................................ 4.90 30 Lora-tabs

The folllowing products no longer have Sole Supply status

24 SULPHASALAZINE

Tab 500 mg (Salazopyrin) & Tab EC 500 mg (Salazopyrin EN)

26 & 125 METOCLOPRAMIDE HYDROCHLORIDE

Inj 5 mg per ml, 2 ml (Pharmacia)

31 GLIBENCLAMIDE

Tab 2.5 mg & tab 5 mg (Gliben)

31 GLIPIZIDE

Tab 5 mg (Glipid)

35 SODIUM CITRATE WITH SODIUM LAURYL SULPHOACETATE

Enema 90 mg with sodium lauryl sulphoacetate (Microlax)

45 BEZAFIBRATE

Tab 200 mg (Bezalip)

45 GEMFIBROZIL

Cap 300 mg (Gemizol)

69 AQUEOUS CREAM

500 g (David Craig)

69 EMULSIFYING OINTMENT BP

500 g (David Craig)

73 BETAMETHASONE VALERATE

Scalp application 0.1% (Beta Scalp), Crm 0.1%, 100 g (Beta Cream) & Oint 0.1%, 100 g (Beta Ointment)

73 CLOBETASOL PROPIONATE

Scalp application 0.05% (Dermol)

73 KETOCONAZOLE

Shampoo 2% (Sebizole)

73 TAR WITH TRIETHANOLAMINE LAURYL SULPHATE AND FLUORESCEIN SODIUM

Soln 2.3% 500 ml & 1,000 ml (Pinetarsol)

81 OXYBUTYNIN

Tab 5 mg (Apo-Oxybutynin)

83 HYDROCORTISONE

Tab 5 mg & tab 20 mg (Douglas)

v Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Sole Supply – effective 1 July 2002 (continued)

84 PREDNISONE

Tab 1 mg, 2.5 mg, 5 mg & 20 mg (Apo-Prednisone)

90 CLOMIPHENE CITRATE

Tab 50 mg (Phenate)

94 ERYTHROMYCIN ETHYL SUCCINATE

Grans for oral liq 200 mg per 5 ml & 400 mg per 5 ml (E-Mycin) Tab 400 mg (E-Mycin)

94 ROXITHROMYCIN

Tab 150 mg & 300 mg (Romicin)

95 AMOXYCILLIN CLAVULANATE

Tab amoxycillin 500 mg with potassium clavulanate 125 mg (Synermox) Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml (Synermox) Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml (Synermox)

95 FLUCLOXACILLIN MAGNESIUM

Grans for oral liq 125 mg per 5 ml (Floxapen) & Grans for oral liq 250 mg per 5 ml (Floxapen)

95 PHENOXYMETHYLPENICILLIN

Cap potassium salt 250 mg & 500 mg (Cilicaine VK)

96 CO-TRIMOXAZOLE

Tab trimethoprim 80 mg/sulphamethoxazole 400 mg (Apo-Sulfatrim) Oral liquid sugar-free trimethoprim 40 mg/sulphamethoxazole 200 mg (Trisul)

97 & 108 TRIMETHOPRIM

Tab 300 mg (TMP)

98 METRONIDAZOLE

Tab 200 mg & tab 400 mg (Trichozole)

108 NORFLOXACIN

Tab 400 mg (Noroxin)

110 IBUPROFEN

Tab 200 mg (Panafen)

111 INDOMETHACIN

Cap 25 & cap 50 mg (Rheumacin) and suppos 100 mg (Arthrexin)

113 ORPHENADRINE CITRATE

Tab 100 mg (Norflex)

116 PARACETAMOL

Tab 500 mg (Panadol)

116 PARACETAMOL WITH CODEINE

Tab paracetamol 500 mg with codeine phosphate 8 mg (Panadeine)

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Sole Supply – effective 1 July 2002 (continued)

118 AMITRIPTYLINE

Tab 10 mg, tab 25 mg & tab 50 mg (Amitrip)

118 CLOMIPRAMINE HYDROCHLORIDE

Tab 10 mg (Anafranil)

118 DOTHIEPIN HYDROCHLORIDE

Cap 25 mg & tab 75 mg (Dopress)

118 DOXEPIN HYDROCHLORIDE

Cap 10 mg, cap 25 mg, cap 50 mg & cap 75 mg (Anten)

118 PETHIDINE HYDROCHLORIDE

Inj 50 mg per ml, 1 ml & inj 50 mg per ml, 2 ml (Baxter)

124 METOCLOPRAMIDE HYDROCHLORIDE WITH PARACETAMOL

Tab 5 mg with paracetamol 500 mg (Paramax)

126 BROMOCRIPTINE MESYLATE

Tab 2.5 mg & Tab 10 mg (Alpha-Bromocriptine)

129 FLUPHENAZINE DECANOATE

Inj 12.5 mg per 0.5 ml, 0.5 ml, inj 25 mg per ml, 1 ml & inj 100 mg per ml, 1 ml (Baxter)

131 TEMAZEPAM

Cap 10 mg (Euhypnos) & cap 20 mg (Somapam)

131 TRIAZOLAM

Tab 0.125 mg & tab 0.250 mg (Halcion)

131 ZOPICLONE

Tab 7.5 mg (Zo-Tab)

145 KETOTIFEN

Oral liq 1 mg per 5 ml (Asmafen)

157 CHLORAMPHENICOL

Eye oint 1% (Chlorsig) & Eye drops 0.5% (Isopto-Fenicol)

159 DIPIVEFRIN HYDROCHLORIDE

Eye drops 0.1% (Dipoquin)

160 LEVOBUNOLOL

Eye drops 0.5% (Alcon-Levobunolol)

160 PILOCARPINE

Eye drops 0.5%, 1%, 2%, 3%, 4% & 6% (Pilopt)

v Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Sole supply –effective 1 May 2002

39 VITAMINS

Tab (BPC cap strength) .................................................. 15.60 1,000 Healtheries Multivitamin tablets

153 SALBUTAMOL WITH IPRATROPIUM BROMIDE - Available on a PSO

Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per 2.5 ml vial, 2.5 ml ... 10.45 20 Duolin

Corrections

Effective 1 July 2002

70 POVIDONE IODINE

Oint 10% - Only on a prescription, maximum 100 g per prescription ................................ 6.87 100 g OP (7.25)

BetadineIMM

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Delisted Items

Effective 1 August 2002

53 CAPTOPRIL

Oral liq 5 mg per ml - restricted to children under twelve years of age ...... 44.38 100 ml OP Note: Replaced by 95 ml pack size, listed 1 February 2002. Capoten

66 BETAMETHASONE VALERATE

Oint 0.1% ......................................................................... 2.25 30 g OP (5.91) Betnovate

76 CONDOMS WITH SPERMICIDE

- Available on a PSO ..................................................... 28.56 (94.68) 144 Durex Extra Safe

133 CHLORAMBUCIL- Retail pharmacy-specialist

Tab 2 mg ........................................................................ 22.35 25 Leukeran Tab 5 mg ........................................................................ 33.18 25 Leukeran Note: 2 mg strength replaced by Leukeran FC (film-coated) tablets, listed 1 February 2002.

Effective 1 July 2002

64 TIOCONAZOLE

92 CEFUROXIME SODIUM

a) Hospital pharmacy [HP3] - Maximum of 750 mg per prescription; or b) Hospital pharmacy [HP3]-specialist - Only if prescribed for a dialysis or cystic fibrosis patient; and - The prescription is endorsed accordingly. Inj 250 mg ..................................................................... 20.97 (27.00)

10 Zinacef

145 LORATADINE

Tab 10 mg ........................................................................ 4.90 (28.72) 30 Claratyne

147 FLUTICASONE

Powder for inhalation, 50 µg per dose, 4 doses per disk . 3.90 15 disks (8.67)

v Three

Flixotide

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Delisted Items – effective 1 July 2002 (continued)

152 FENOTEROL HYDROBROMIDE WITH IPRATROPIUM BROMIDE - Special Authority

Nebuliser soln, 1.25 mg with ipratropium bromide, 500 µg per 4 ml ........................ 11.25 (15.00) 20 Duovent Respules

Effective 1 June 2002

32 GLUCOSE OXIDASE

Blood diagnostic test with peroxidase ............................ 27.85 50 test OP (36.11) Glucostix Glucofilm

36 MOUTHWASH

Tab ................................................................................ 14.25 (23.45) 500 Solucol

46 PRAVASTATIN - Special Authority

Tab 10 mg ........................................................................ 7.90 (35.30) Tab 20 mg ...................................................................... 15.96 (50.00) 30 Lipostat 30 Lipostat

66 BETAMETHASONE VALERATE

Crm 0.1% ......................................................................... 2.25 30 g OP (5.38) Bivate

67 & 170 HYDROCORTISONE WITH WOOL FAT AND MINERAL OIL - Only on the prescription of a doctor

Lotn 1% with wool fat hydrous 3% and mineral oil .......... 2.86 (4.77) 100 ml BK Lotn HC

73 BETAMETHASONE DIPROPIONATE

Scalp lotn propylene glycol base 0.05% .......................... 8.00 30 ml OP (11.40) Diprolene

78 ETHINYLOESTRADIOL WITH LEVONORGESTREL - Available on a PSO

Tab ethinyloestradiol 30 µg with levonorgestrel 50 µg (6) and tab ethinyloestradiol 40 µg with levonorgestrel 75 µg (5) and tab ethinyloestradiol 30 µg with levonorgestrel 125 µg (10) .. 3.15 (4.83)

21 Triphasil 21

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Delisted Items – effective 1 June 2002 (continued)

81 OESTROGENS

Conjugated, equine vaginal crm 625 µg per g with applicator .............................................................. 6.49 42 g OP Premarin

94 ERYTHROMYCIN ETHYL SUCCINATE

Inj 50 mg per ml, 2ml ...................................................... 9.91 5 ERA

94 ERYTHROMYCIN LACTOBIONATE

Inj 300 mg ....................................................................... 5.34 (6.22) 1 ERA

110 NAPROXEN - Special Authority available

Tab 250 mg .................................................................... 30.00 Tab 500 mg .................................................................... 12.00 Tab EC 500 mg ................................................................ 8.80 500 100 60 Noflam Noflam Noflam EC

111 NAPROXEN SODIUM - Special Authority available

Tab 275 mg ...................................................................... 6.40 Tab 550 mg .................................................................... 12.80 100 100 Noflam-N Noflam-N

130 DIAZEPAM - Month restriction

Tab 2 mg .......................................................................... 5.42 500 D-Pam

146 BECLOMETHASONE DIPROPIONATE

Aerosol inhaler, 50 µg per dose ....................................... 8.54 200 dose OP (17.08) Atomide Junior Aerosol inhaler, 100 µg per dose ................................... 12.50 200 dose OP (25.00) Atomide Aerosol inhaler, 250 µg per dose ................................... 22.67 200 dose OP (45.33) Atomide Forte

154 THEOPHYLLINE

Cap long-acting 300 mg ................................................ 25.28 (42.00) 100 Nuelin-24

177 RESOURCE JUST FOR KIDS

Strawberry ....................................................................... 1.90 237 ml OP

v Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Delisted Items – effective 1 May 2002

39 VITAMINS

Tab (BPC cap strength) .................................................. 15.60 (25.00) 1000 Apo-Multivitamin Multivite Six

43 WARFARIN SODIUM

Tab 2.5 mg ....................................................................... 4.71

Coumadin

146 BUDESONIDE

Aerosol inhaler, 200 µg per dose ................................... 18.14 200 dose OP (36.26) Pulmicort

153 SALBUTAMOL WITH IPRATROPIUM BROMIDE - Available on a PSO

Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per 2.5 ml vial, 2.5 ml ... 10.45 (11.20) 20 Combivent Respules

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Items to be Delisted

Effective 1 February 2003

46 FLUVASTATIN

Cap 20 mg ....................................................................... 6.38 (23.10) Cap 40 mg ....................................................................... 7.51 (27.00) 30 VastinIMM 30 VastinIMM

74 & 168 PODOPHYLLIN

Paint 20% ....................................................................... CE a) Maximum 20 ml per prescription 20 ml

78 ETHINYLOESTRADIOL WITH LEVONORGESTREL - Available on a PSO

Tab ethinyloestradiol 50 µg with levonorgestrel 50 µg (11) and tab ethinyloestradiol 50 µg with levonorgestrel 125 µg (10) and 7 inert tab ....................................... 3.15 (4.60)

28 Biphasil 28 Asendin

118 AMOXAPINE

Tab 50 mg ...................................................................... 26.00 100

149 FENOTEROL HYDROBROMIDE - Special Authority

Aerosol inhaler, 200 µg per dose ................................... 15.00 300 dose OP (18.00) Berotec

152 FENOTEROL HYDROBROMIDE WITH IPRATROPIUM BROMIDE - Special Authority

Aerosol inhaler, 100 µg with ipratropium bromide, 40 µg per dose ........................................................... 13.50 200 dose OP (18.00) Duovent Inhaler

154 THEOPHYLLINE

Tab long-acting 200 mg ................................................. 11.00 (12.00) 100 Theo-Dur 25 g PSM 227 g OP

171 PODOPHYLLIN RESIN .................................................. 31.40

(34.50)

179 RESOURCE THICKEN UP ............................................... 4.00

Note: Replaced by 250 g OP listed 1 August 2002. ,

v Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Items to be delisted – effective 1 January 2003

23 & 116 CODEINE PHOSPHATE

Tab 15 mg ........................................................................ 7.60 Tab 30 mg ...................................................................... 10.60 Tab 60 mg ...................................................................... 20.10 (22.00) 100 100 100 Douglas Douglas Douglas

24 SULPHASALAZINE

Suppos 500 mg ............................................................... 6.99 (7.50) 10 Salazopyrin

34 MUCILAGINOUS LAXATIVES - Only on a prescription

Dry .................................................................................. 2.64 150 g OP (4.75) Isogel

44 POTASSIUM CHLORIDE

Inj 75 mg per ml, 10 ml ................................................. 30.16 50 Pharmacia Zocor Zocor Zocor

46 SIMVASTATIN

Tab 10 mg ...................................................................... 11.10 Tab 20 mg ...................................................................... 13.50 Tab 40 mg ...................................................................... 24.00 30 30 30

53 LISINOPRIL

Tab 5 mg .......................................................................... 4.91 (12.28) Tab 10 mg ........................................................................ 7.14 (17.86) Tab 20 mg ...................................................................... 10.10 (25.27) 30 ZestrilIMM 30 ZestrilIMM 30 ZestrilIMM

54 LISINOPRIL WITH HYDROCHLOROTHIAZIDE

Tab 20 mg with hydrochlorothiazide 12.5 mg ................ 10.70 (38.04) 30 Prinzide Zestoretic

57 PINDOLOL WITH CLOPAMIDE

Tab 10 mg with clopamide 5 mg ...................................... 3.15 (7.10) 30 Viskaldix

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Items to be delisted – effective 1 January 2003 (continued)

66 BETAMETHASONE DIPROPIONATE

Crm 0.05% in propylene glycol base ............................... 4.33 30 g OP (12.20) Note: Diprosone OV listed 1 July 2002 to replace Diprolene cream. Diprolene

80 TIOCONAZOLE

Pessaries 100 mg with applicator .................................... 2.75 (9.20) 3 Gyno-Trosyd

107 ZALCITABINE (ddC) - Special Authority

Tab 750 µg ................................................................... 344.50 100 Hivid

115 LIGNOCAINE HYDROCHLORIDE - Available on a PSO

Inj 1% 20 ml vial ............................................................ 23.70 5 (26.16) Xylocaine Inj 1% 50 ml vial ............................................................ 35.20 5 (38.80) Xylocaine a) Only if prescribed on prescription for a dialysis patient or child with rheumatic fever or on a PSO for emergency use.

130 CHLORDIAZEPOXIDE HYDROCHLORIDE - Month restriction

Cap 5 mg ......................................................................... 4.77 (5.35) Cap 10 mg ....................................................................... 4.95 (5.54) 100 Nova-Pam 100 Nova-Pam

133 CYTARABINE - Retail pharmacy-specialist

Inj 1 g ........................................................................... 118.00 Inj 2 g ........................................................................... 150.00 each each Pharmacia Pharmacia

134 METHOTREXATE - Hospital pharmacy [HP1]-specialist

Inj 500 mg, 20 ml vial [HP1] .......................................... 80.25 (82.66) each Pharmacia

147 BECLOMETHASONE DIPROPIONATE

Powder for inhalation, 200 µg per dose, 8 doses per disk ......................................................... 13.50 15 disks (18.90)

Becodisk 200

149 SALBUTAMOL - Available on a PSO

Powder for inhalation, 50 µg per dose, breath activated ...... 10.61 200 dose OP Salbutamol Turbuhaler

v Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Items to be delisted – effective 1 January 2003 (continued)

154 PHOLCODINE

‡ Linctus BP ...................................................................... 11.00 2,000 ml (22.00) ‡ Linctus strong BP ........................................................... 13.00 2,000 ml (27.50) Douglas Douglas

156 & 158 BETAMETHASONE SODIUM PHOSPHATE

Ear/Eye drops 0.1% ......................................................... 4.50 5 ml OP Betnesol

156 & 158 BETAMETHASONE SODIUM PHOSPHATE WITH NEOMYCIN

Ear/Eye drops 0.1% with neomycin sulphate 0.5% .......... 4.50 5 ml OP Betnesol-N 10 ml OP Dipoquin

159 DIPIVEFRIN HYDROCHLORIDE - Retail pharmacy-specialist

Eye drops 0.1% ................................................................ 5.90

Effective 1 December 2002

28 BISMUTH SUBNITRATE

Tab 300 mg with frangula bark 25 mg, magnesium carbonate 400 mg and sodium bicarbonate 200 mg ................... 13.50 120 Roter Gestone

88 PROGESTERONE

Inj 25 mg per ml, 1 ml ................................................... 23.29 10

110 KETOPROFEN - Special Authority available

Cap long-acting 200 mg ................................................ 13.44 (32.40) 100 Kefen SR

Effective 1 November 2002

24 PREDNISOLONE SODIUM PHOSPHATE

Enema 20 mg 100 ml .................................................... 17.33 7 Predsol

45 POTASSIUM CHLORIDE

Tab long-acting 600 mg ................................................. 12.31 (16.93) 500 Span K LescolIMM LescolIMM

‡ safety cap reimbursed Sole supplier

46 FLUVASTATIN

Cap 20 mg ....................................................................... 6.38 Cap 40 mg ....................................................................... 7.51 30 30

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Items to be delisted – effective 1 November 2002 (continued)

83 HYDROCORTISONE

Inj 125 mg per ml, 2 ml - Only on a PSO ......................... 7.85 Inj 125 mg per ml, 4 ml - Only on a PSO ....................... 13.28 1 1 Solu-Cortef Solu-Cortef

137 INTERFERON ALPHA-2B - Special Authority

Inj 3 m iu, 0.5 ml single dose vial ................................ 156.60 5 Intron-A Inj 5 m iu, 0.5 ml single dose vial ................................ 261.00 5 Intron-A Inj 10 m iu solution ...................................................... 522.00 5 Intron-A Inj 18 m iu, 3 ml multidose vial .................................... 187.92 1 Intron-A Inj 25 m iu solution ................................................... 1,305.00 5 Intron-A Note: Inj 18, 30 and 60 m iu multidose pens remain listed and fully subsidised.

149 SALBUTAMOL

Powder for inhalation, 200 µg per dose, 8 doses per disk ... 8.12 15 disks Ventodisk

Effective 1 October 2002

159 BETAXOLOL HYDROCHLORIDE - Retail pharmacy-specialist

Eye drops 0.5% ................................................................ 7.54 (15.08)

5 ml OP Betoptic

Effective 1 September 2002

152 IPRATROPIUM BROMIDE - Available on a PSO

Nebuliser soln, 250 µg per 1 ml, 1 ml ............................. 5.90 (7.80) Nebuliser soln, 500 µg per 2 ml, 2 ml ............................. 7.55 (11.20) 20 Steri-Nebs 20 Steri-Nebs

Effective 1 June 2002

155 PEAK FLOW METERS - Only on a WSO

002 ay 2 M Normal range - maximum 10 per WSO .......................... 17.00 d1 tate ns Rei

1 OP

Mini Wright

v Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Index

Pharmaceuticals and brands Betamethasone valerate ....................... 31, 35, 36 Betaxolol hydrochloride ........................ 17, 28, 43 Betnesol .............................................................. 42 Betnesol-N .......................................................... 42 Betnovate ............................................................ 35 Betoptic ....................................................... 28, 43 Bezafibrate .......................................................... 31 Bezalip ................................................................ 31 Biphasil 28 .......................................................... 39 Bismuth subnitrate .............................................. 42 Bivate .................................................................. 36 BK Lotn HC ......................................................... 36 Bromocriptine mesylate ............................... 27, 33 Budesonide ......................................................... 38 Budesonide with eformoterol .............................. 24

Acetylcysteine ..................................................... 30 Alcon-Levobunolol .............................................. 33 Alendronate ......................................................... 28 Allegron .............................................................. 27 Alpha-Bromocriptine .................................... 27, 33 Amitrip ................................................................ 33 Amitriptyline ........................................................ 33 Amorolfine .......................................................... 20 Amoxapine .......................................................... 39 Amoxycillin clavulanate ................................ 27, 32 Anafranil ............................................................. 33 Anten .................................................................. 33 Anusol ................................................................ 28 Apo-Betaxolol .............................................. 17, 28 Apo-Ethambutol .................................................. 27 Apo-Multivitamin ................................................. 38 Apo-Oxybutynin .................................................. 31 Apo-Prednisone ........................................... 26, 32 Apo-Sulfatrim ...................................................... 32 Aquabloc 30+ ............................................. 28, 29 Aquasun 30+ .............................................. 28, 29 Aqueous cream ................................................... 31 Arava .................................................................. 17 Arthrexin ............................................................. 32 Asendin ............................................................... 39 Asmafen ............................................................. 33 Atomide .............................................................. 37 Atomide Forte ..................................................... 37 Atomide Junior .................................................... 37 Atorvastatin ........................................................ 18 Atrovent Nasal Aqueous ...................................... 27

Calamine ............................................................. 21 Calcitriol .............................................................. 25 Canesten ............................................................. 20 Capoten ....................................................... 25, 35 Captopril ...................................................... 25, 35 Catapres ............................................................. 26 Ceftriaxone sodium ............................................. 16 Cefuroxime sodium ............................................. 35 Cephazolin sodium .............................................. 16 Chlorambucil ....................................................... 35 Chloramphenicol .......................................... 16, 33 Chlordiazepoxide hydrochloride .......................... 41 Chlorsig ....................................................... 16, 33 Ciclopiroxolamine ................................................ 20 Cilicaine VK ......................................................... 32 Claratyne ............................................................. 35 Clobetasol propionate .................................. 26, 31 Clocreme ............................................................ 20 Clomiphene citrate .............................................. 32 Clomipramine hydrochloride ............................... 33 Clonidine ............................................................. 26 Clonidine hydrochloride ...................................... 27 Clotrimazole ........................................................ 20 Co-trimoxazole .................................................... 32 Coal tar with salicyclic acid and sulphur ............. 16 Cocois ................................................................ 16 Codeine phosphate ............................................. 40 Colchicine ........................................................... 27 Combivent Respules ........................................... 38 Condoms with spermicide .................................. 35 Coumadin ........................................................... 38 Crotamiton .......................................................... 22

Bactroban ........................................................... 19 Batrafen .............................................................. 20 Beclomethasone dipropionate ...................... 37, 41 Becodisk 200 ...................................................... 41 Berotec ............................................................... 39 Beta Cream ......................................................... 31 Beta Ointment ..................................................... 31 Beta Scalp .......................................................... 31 Betadine .............................................................. 34 Betamethasone dipropionate ................ 16, 36, 41 Betamethasone dipropionate with clotrimazole .... 22 Betamethasone dipropionate with salicylic acid .. 22 Betamethasone sodium phosphate ..................... 42 Betamethasone sodium phosphate with neomycin ................................................. 42

Cyclosporin A ..................................................... 19 Cyklokapron ........................................................ 28 Cytarabine ........................................................... 41

D-Pam ................................................................ 37 Daktarin .............................................................. 21 ddC ..................................................................... 41 Dermol ......................................................... 26, 31 Diazepam ............................................................ 37 Dipentum ............................................................ 26 Dipivefrin hydrochloride ............................... 33, 42 Dipoquin ...................................................... 33, 42 Diprolene ..................................................... 36, 41 Diprosalic ............................................................ 22 Diprosone OV ...................................................... 16 Dithranol ............................................................. 16 Dixarit ................................................................. 27 Docusate sodium with sennosides ...................... 16 Dopress .............................................................. 33 Dothiepin hydrochloride ...................................... 33 Doxepin hydrochloride ........................................ 33 Duolin ................................................................. 34 Duovent Inhaler ................................................... 39 Duovent Respules ............................................... 36 Durex Extra Safe ................................................. 35

Fluvastatin .................................................... 39, 42 Foradil ................................................................. 24 Fosamax ............................................................. 28 Framycetin sulphate with gramicidin ................... 19 Fucidin ................................................................ 19 Fusidic acid ......................................................... 19

Gemfibrozil .......................................................... 31 Gemizol ............................................................... 31 Gestone .............................................................. 42 Gliben .......................................................... 26, 31 Glibenclamide .............................................. 26, 31 Glipid .................................................................. 31 Glipizide .............................................................. 31 Glucofilm ............................................................ 36 Glucose oxidase .................................................. 36 Glucostix ............................................................. 36 Glycerol .............................................................. 30 Glyceryl trinitrate .......................................... 16, 28 Glytrin ................................................................. 16 Gyno-Trosyd ....................................................... 41

Halcion ............................................................... 33 Healtheries Multi-vitamin tablets ......................... 34 Hivid ................................................................... 41 Horleys Bread Mix ............................................... 30 Horleys Flour ...................................................... 30 Hydrocortisone ............................................ 31, 43 Hydrocortisone with wool fat and mineral oil ...... 36

E-Mycin .............................................................. 32 Econazole nitrate ................................................. 20 Ecreme ............................................................... 20 Eformoterol fumarate ................................... 23, 24 Emulsifying ointment BP ..................................... 31 ERA .................................................................... 37 Erythromycin ethyl succinate ....................... 32, 37 Erythromycin lactobionate .................................. 37 Erythropoietin Beta .............................................. 17 Ethambutol .......................................................... 27 Ethinyloestradiol with gestodene ......................... 26 Ethinyloestradiol with levonorgestrel .... 26, 36, 39 Ethynodiol diacetate ............................................ 26 Euhypnos ............................................................ 33 Eurax .................................................................. 22

Ibuprofen ............................................................ 32 Indomethacin ...................................................... 32 Infasoy ................................................................ 29 Interferon alpha-2B ............................................. 43 Intron-A .............................................................. 43 Ipra 250 .............................................................. 29 Ipra 500 .............................................................. 29 Ipratropium bromide ............................ 27, 29, 43 Isogel .................................................................. 40 Isopto-Fenicol ..................................................... 33

Kefen SR ............................................................. 42 Ketoconazole ............................................... 20, 31 Ketoprofen .......................................................... 42 Ketotifen ............................................................. 33

Femodene 21 ...................................................... 26 Femodene 28 ...................................................... 26 Femulen .............................................................. 26 Fenoterol hydrobromide ...................................... 39 Fenoterol hydrobromide with ipratropium bromide .......................... 36, 39 Flixotide .............................................................. 35 Floxapen ............................................................. 32 Flucloxacillin magnesium .................................... 32 Fluphenazine decanoate ...................................... 33 Fluticasone ......................................................... 35

Laxsol ................................................................. 16 Leflunomide ........................................................ 17 Lescol ................................................................. 42 Leukeran ............................................................. 35 Levobunolol ........................................................ 33 Levonorgestrel .................................................... 30 Lignocaine hydrochloride .................................... 41

Lipitor ................................................................. 18 Lipostat ............................................................... 36 Lisinopril ............................................................. 40 Lisinopril with hydrochlorothiazide ...................... 40 Lithium carbonate ............................................... 28 Loceryl ............................................................... 20 Lora-tabs ............................................................ 31 Loratadine .................................................... 31, 35 Lotricomb ........................................................... 22

Oestrogens ......................................................... 37 Olsalazine ........................................................... 26 Orphenadrine citrate ............................................ 32 Oxis Turbuhaler ............................................ 23, 24 Oxybutynin .......................................................... 31

Pamol .......................................................... 22, 29 Panadeine ........................................................... 32 Panadol ............................................................... 32 Panafen ............................................................... 32 Paracare Double Strength Suspension ................ 22 Paracare Junior Suspension ................................ 22 Paracetamol ......................................... 22, 29, 32 Paracetamol with codeine ................................... 32 Paraffin ............................................................... 30 Paramax .............................................................. 33 Parvolex .............................................................. 30 Peak flow meters ................................................ 43 Pethidine hydrochloride ....................................... 33 Pevaryl ................................................................ 20 Phenate ............................................................... 32 Phenoxymethylpenicillin ...................................... 32 Pholcodine .......................................................... 42 Pilocarpine .......................................................... 33 Pilopt .................................................................. 33 Pindolol with clopamide ...................................... 40 Pinetarsol ............................................................ 31 Podophyllin ......................................................... 39 Podophyllin resin ................................................ 39 Polynoxylin ......................................................... 19 Ponoxylan ........................................................... 19 Potassium chloride ...................................... 40, 42 Povidone iodine ............................................ 30, 34 Pravastatin .......................................................... 36 Prednisolone sodium phosphate ......................... 42 Prednisone ................................................... 26, 32 Predsol ............................................................... 42 Premarin ............................................................. 37 Priadel ................................................................. 28 Prinzide ............................................................... 40 Probenecid .......................................................... 17 Progesterone ...................................................... 42 PSM Paracetamol Elixir Paediatric ....................... 22 Pulmicort ............................................................ 38

Methotrexate ....................................................... 41 Metoclopramide hydrochloride ............................ 31 Metoclopramide hydrochloride with paracetamol ............................................ 33 Metronidazole ..................................................... 32 Micanol ............................................................... 16 Miconazole nitrate ............................................... 21 Micreme ............................................................. 21 Microgynon 30 ................................................... 26 Microgynon 30 ED .............................................. 26 Microlax .............................................................. 31 Microlut .............................................................. 30 Mini Wright ......................................................... 43 Morphine hydrochloride ...................................... 27 Mouthwash tab ................................................... 36 Mucilaginous laxatives ........................................ 40 Multivite Six ........................................................ 38 Mupirocin ............................................................ 19 Mycostatin .......................................................... 21 Mylanta ............................................................... 28 Mylanta P ............................................................ 29

Naprosyn SR 750 ............................................... 16 Naproxen ..................................................... 16, 37 Naproxen sodium ................................................ 37 Naprosyn SR 1000 ............................................. 16 Neoral ................................................................. 19 Nifuran ................................................................ 28 Nilstat ................................................................. 21 Nitrofurantoin ...................................................... 28 Nitrolingual Pumpspray ....................................... 28 Nizoral ................................................................ 20 Noflam ................................................................ 37 Noflam EC ........................................................... 37 Noflam-N ............................................................ 37 Norflex ................................................................ 32 Norfloxacin ......................................................... 32 Noroxin ............................................................... 32 Nortriptyline hydrochloride .................................. 27 Nova-Pam ........................................................... 41 Nuelin-24 ............................................................ 37 Nystatin .............................................................. 21

Quetiapine ........................................................... 23

R V Paque ........................................................... 29 RA-Morph ........................................................... 27 Recormon ........................................................... 17 Resource Just for Kids ........................................ 37

Resource Thicken Up ................................... 16, 39 Rheumacin .......................................................... 32 Rocaltrol solution ................................................ 25 Romicin .............................................................. 32 Roter ................................................................... 42 Roxithromycin ..................................................... 32

Salazopyrin .......................................... 26, 31, 40 Salazopyrin EN ............................................. 26, 31 Salbutamol ................................................... 41, 43 Salbutamol Turbuhaler ........................................ 41 Salbutamol with ipratropium bromide ........... 34, 38 Salicylic acid ....................................................... 30 Salmeterol .................................................... 23, 24 Sebizole .............................................................. 31 Serevent ...................................................... 23, 24 Serevent Accuhaler ............................................. 24 Seroquel ............................................................. 23 Silvazine .............................................................. 20 Silver sulphadiazine ............................................ 20 Simethicone ................................................. 28, 29 Simvastatin ......................................................... 40 Sodium citrate with sodium lauryl sulphoacetate ......................................... 31 Soframycin ......................................................... 19 Solu-Cortef ......................................................... 43 Solucol ............................................................... 36 Somapam ........................................................... 33 Span K ................................................................ 42 Steri-Nebs .................................................... 29, 43 Sulphasalazine ..................................... 26, 31, 40 Sunscreens, proprietary ............................... 28, 29 Symbicort Turbuhaler 100/6 ............................... 24 Symbicort Turbuhaler 200/6 ............................... 24 Synermox .................................................... 27, 32

Temazepam ......................................................... 33 Tetrabenazine ...................................................... 29 Theo-Dur ............................................................ 39 Theophylline ................................................. 37, 39 Tinaderm ............................................................ 21 Tioconazole .......................................... 21, 35, 41 TMP .................................................................... 32 Tolciclate ............................................................. 21 Tolmicen ............................................................. 21 Tolnaftate ............................................................ 21 Tranexamic acid .................................................. 28 Triazolam ............................................................ 33 Trichozole ........................................................... 32 Trimethoprim ....................................................... 32 Triphasil 21 ......................................................... 36 Trisul ................................................................... 32 Trosyd .......................................................... 21, 35

Vastin .................................................................. 39 Ventodisk ............................................................ 43 Viodine ................................................................ 30 Viskaldix ............................................................. 40 Vitamins ....................................................... 34, 38

Warfarin sodium ................................................. 38

Xenazine 25 ........................................................ 29 Xylocaine ............................................................ 41

Zalcitabine ........................................................... 41 Zestoretic ............................................................ 40 Zestril .................................................................. 40 Zinacef ................................................................ 35 Zinc and castor oil ............................................... 29 Zinc oxide ........................................................... 28 Zo-Tab ................................................................. 33 Zocor .................................................................. 40 Zopiclone ............................................................ 33

Tar with triethanolamine lauryl sulphate and fluorescein .................................. 31

While care has been taken in compiling this Update, Pharmaceutical Management Agency takes no responsibility for any errors or omissions and shall not be liable to any person for any damages or loss arising out of reliance by that person for any purpose on any of the contents of this Update. Errors and omissions brought to the attention of Pharmaceutical Management Agency will be corrected if necessary by an erratum or otherwise in the next edition of the Update. Pharmaceutical Management Agency Level 1 Old Bank Chambers Cnr Hunter Street & Customhouse Quay Freepost 4072 PO Box 10 254 Wellington New Zealand Telephone 64 4 460 4990 Facsimile 64 4 460 4995 Freephone 0800 660050 http://www.pharmac.govt.nz

Metadata

Title

Schedule Update - effective 1 August 2002

Abstract

Pharmaceutical Management Agency, New Zealand. Pharmaceutical Schedule UPDATE Effective 1 August 2002. Cumulative Update for May, June, July & August 2002.

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.